NSE Stock Analysis > SUNPHARMA
Is SUNPHARMA a good investment for 2026? Our technical systems have analyzed the latest market indicators.
**SUNPHARMA Share Price Target 2030:** As of today, SUNPHARMA is trading at **₹1729.9**.The stock is currently showing stable momentum with a neutral RSI of 44.4. Based on our growth models, we project a potential long-term upside to **₹5081.0** by 2030. **Verdict:** The technical rating is SUNPHARMA as a **BUY** opportunity.
Based on our technical analysis, SUNPHARMA is currently rated as a BUY, driven by an RSI of 44.4 and Normal volume activity.
Based on the current CAGR of 24.05%, we project SUNPHARMA could reach approximately ₹5081.0 by the year 2030.
The RSI is neutral.